M6Q-31364-65810
3 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 16-20
- ZIP prefix
- 207 / MD
- Registered
- 2021-11-19
- Relationship
- Child or adolescent in my care
- Guardian
- UDD-17873-33041
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-16
Dose 1 — Pfizer-BioNTech
-
2021-06-06
Dose 2 — Pfizer-BioNTech
-
2021-11-19
Registered in v-safe
- 2021-12-05
-
2021-12-29
Dose 3 — Pfizer-BioNTech
- 2022-01-03
- 2022-01-04
- 2022-01-05
- 2022-01-13
- 2022-01-19
- 2022-01-26
- 2022-02-02
- 2022-02-10
-
2022-03-30
Survey response — 3 months, dose 3, dependentMedDRA: Abdominal pain upper, Diarrhoea, Nausea — Feeling: Good · Be unable to work or attend schoolFree text: Stomach pain, nausea, diarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-07-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-16 | Pfizer-BioNTech | No |
| 2 | 2021-06-06 | Pfizer-BioNTech | No |
| 3 | 2021-12-29 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 3, dependent
Symptoms: Stomach pain, nausea, diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release